Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy
Completed · Phase 3
Conditions studied: Prostate Adenocarcinoma, Recurrent Prostate Carcinoma
In brief
This clinical trial studies how well gallium Ga 68-labeled prostate-specific membrane antigen (PSMA)-11 positron emission tomography (PET)/computed tomography (CT) works in detecting prostate cancer that has come back (recurrent) in patients after initial therapy. Diagnostic procedures, such as gallium Ga 68-labeled PSMA-11 PET/CT, may help doctors detect tumors that have come back after initial therapy.
Key facts
- Study ID
- NCT02940262
- Run by
- Jonsson Comprehensive Cancer Center
- People needed
- 1138
- Starts
- 2016-09-15
- Expected to finish
- 2021-06-18
- Last updated by the study team
- 2021-07-02
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Histopathological proven prostate adenocarcinoma
- Rising PSA after definitive therapy with prostatectomy or radiation therapy.
- Post radical prostatectomy (RP)
- PSA equals to or greater than 0.2 ng/mL measured more than 6 weeks after RP
- Post-radiation therapy - American Society for Therapeutic Radiation and Oncology (ASTRO)-Phoenix consensus definition
- Nadir + greater than or equal to 2 ng/mL rise in PSA
- Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/ World Health Organization [WHO] equivalent)
- Ability to understand a written informed consent document, and the willingness to sign it
You may not qualify if…
- Concomitant investigational therapy
- Known inability to lie flat, remain still or tolerate a PET scan
- Patient undergoing active treatment for non-prostate malignancy, other than skin basal cell or cutaneous superficial squamous cell carcinoma that has not metastasized and superficial bladder cancer
Where it is running
- UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.